Column Group Opportunity III, LP

10% owner at Surrozen, Inc./DE · on record since Mar 28, 2025
10% owner at Eikon Therapeutics, Inc. · on record since Feb 9, 2026
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Oct 31, 2022
10% owner at Tenaya Therapeutics, Inc. · on record since Nov 23, 2022

Insider trading activity of Column Group Opportunity III, LP

Transactions on record: 39; since Jan 17, 2023

Open-market buys: 7; $50.1M

Open-market sells: 0

Companies traded: 3; last filing Feb 9, 2026

Figures computed from official regulatory filings — .

Companies where Column Group Opportunity III, LP has traded

Eikon Therapeutics, Inc.17 tx · $38.1M · Feb 9, 2026
Surrozen, Inc./DE21 tx · $12M · Mar 28, 2025
NGM BIOPHARMACEUTICALS INC1 tx · $26.6K · Jan 17, 2023

Track record of Column Group Opportunity III, LP

Statistical track record

Free account

Open-market buys: 17

Last buy: Feb 6, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of Column Group Opportunity III, LP

Co-insiders of Column Group Opportunity III, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-28,229	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-330,000	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	47,898	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	1,437,323	18.00 USD	$25.9M	conv 74ClusterUnusual size	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-9,670,000	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-10,467,526	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	44,249	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	49,556	18.00 USD	$892K	conv 51Cluster	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	1,296,629	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	3,785	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	630,881	18.00 USD	$11.4M	conv 81ClusterUnusual size	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-827,278	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-5,133,076	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	1,403,568	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-357,216	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	688,283	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	110,928	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-90,897	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	182,884	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-352,225	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	161,943	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	Buy	365,769	11.60 USD	$4.2M	conv 77First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-397,773	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	90,897	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	98,870	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-28,229	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-330,000	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	47,898	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	1,437,323	18.00 USD	$25.9M	conv 74ClusterUnusual size	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-9,670,000	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-10,467,526	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	44,249	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	49,556	18.00 USD	$892K	conv 51Cluster	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	1,296,629	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	3,785	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Buy	630,881	18.00 USD	$11.4M	conv 81ClusterUnusual size	SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-827,278	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-5,133,076	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	1,403,568	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	OtherD (derivative)	-357,216	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	688,283	—	n/a (No price was disclosed in the filing)		SEC
Eikon Therapeutics, Inc.Listing unverified	Feb 9, 2026	Other	110,928	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-90,897	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	182,884	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-352,225	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	161,943	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	Buy	365,769	11.60 USD	$4.2M	conv 77First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	OtherD (derivative)	-397,773	—	n/a (No price was disclosed in the filing)		SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	90,897	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Surrozen, Inc./DEListing on record	Mar 28, 2025	BuyD (derivative)	98,870	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC